lutein has been researched along with isoproterenol in 1 studies
Studies (lutein) | Trials (lutein) | Recent Studies (post-2010) (lutein) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
---|---|---|---|---|---|
2,770 | 267 | 1,422 | 30,780 | 803 | 2,640 |
Protein | Taxonomy | lutein (IC50) | isoproterenol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abd-Elmawla, MA; Abdelmonem, M; Amin, HAA; Essam, RM; Ibrahim, SM | 1 |
1 other study(ies) available for lutein and isoproterenol
Article | Year |
---|---|
Lutein exerts its cardioprotective effect against the experimental model of isoprenaline-induced myocardial infarction via MIAT/miR-200a/Nrf2/TXINP pathway.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Isoproterenol; Lutein; MicroRNAs; Myocardial Infarction; NF-E2-Related Factor 2; Rats; RNA, Long Noncoding; Signal Transduction | 2021 |